ID: ALA594704

Max Phase: Preclinical

Molecular Formula: C18H18N2OS

Molecular Weight: 310.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccccc1N1CCN(c2csc3ccccc23)CC1

Standard InChI:  InChI=1S/C18H18N2OS/c21-17-7-3-2-6-15(17)19-9-11-20(12-10-19)16-13-22-18-8-4-1-5-14(16)18/h1-8,13,21H,9-12H2

Standard InChI Key:  QDZJJQIHWPTANT-UHFFFAOYSA-N

Associated Targets(non-human)

Intestinal alkaline phosphatase 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.42Molecular Weight (Monoisotopic): 310.1140AlogP: 3.93#Rotatable Bonds: 2
Polar Surface Area: 26.71Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.20CX Basic pKa: 2.19CX LogP: 4.39CX LogD: 4.39
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.78Np Likeness Score: -0.96

References

1. Li L, Chang L, Pellet-Rostaing S, Liger F, Lemaire M, Buchet R, Wu Y..  (2009)  Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.,  17  (20): [PMID:19781951] [10.1016/j.bmc.2009.08.048]

Source